-
-representation of people living in low-middle income settings in genetic NMD cohorts. We have created a comprehensive genetic and phenotypic database of participants from around the world and connect experts
-
About us The Alzheimer's Research UK Drug Discovery Institute at University College London (ARUK UDDI) is a member of the Alzheimer’s Research UK funded Dementia Discovery Alliance (DDA) – a highly
-
international CANCAN Cancer Grand Challenge Team. Prof. Mariam Jamal-Hanjani is Principal Investigator of the TRACERx study at UCL, Chief Investigator of the PEACE study and a co-PI within the international
-
short-read, long-read, and transcriptome data. There is also the potential to develop and publish novel analytical approaches. This is a unique opportunity to work alongside clinical experts
-
to optimise the mutiplexed readout. You will also work with leading experts in both academic and industrial sectors. This is 11 months full-time project, to begin in June 2026 or soon after. Requirements and
-
About us Our mission is to maximise and advocate for the holistic health of all children, young people and the adults they will become, through world-class research, education and public engagement
-
the last 120 years. We embrace collaboration and excellence to create a future that is inclusive and just and have been ranked number one for education every year since 2014 in the QS World University
-
About us The UK Dementia Research Institute (UK DRI) is a globally leading multidisciplinary research institute of over 900 staff investigating the spectrum of neurodegenerative disorders causing